How pharmaceutical companies are driving positive social change
Sustainability and corporate social responsibility (CSR) strategies have shown huge success across industries. The benefits include...
Contributors
-
Account Manager -
Associate Consultant -
President, USA -
-
Publications Executive -
Project Director -
Associate Consultant -
Consultant -
Consultant -
Senior Consultant -
SVP -
Master Practitioner: Patient Insights -
Publications Assistant -
EVP, Oncology Practice Head -
Senior Strategy Consultant -
Chief Commercial Officer -
US CEO -
Account Manager -
Senior Consultant -
Associate Editorial Director -
Sr. Research Analyst -
Associate Consultant -
Principal -
Research Executive -
Account Director -
Consultant -
Vice President -
Head of MedErgy (CH-MedErgy) -
Project Manager -
Project Manager -
Managing Consultant -
Senior Consultant -
Project Director -
Executive Vice President, Strategic Collaborations -
Associate Consultant
Cello Health Archive
- September 2019 (2)
- August 2019 (4)
- July 2019 (4)
- June 2019 (4)
- May 2019 (12)
- April 2019 (11)
- March 2019 (5)
- February 2019 (12)
- January 2019 (1)
- October 2018 (2)
- August 2018 (5)
- July 2018 (7)
- June 2018 (5)
- May 2018 (5)
- April 2018 (6)
- March 2018 (9)
- February 2018 (11)
- January 2018 (4)
- December 2017 (8)
- November 2017 (21)
- October 2017 (35)
- September 2017 (18)
- August 2017 (1)
- July 2017 (1)
- June 2017 (1)
- May 2017 (2)
- April 2017 (2)
- March 2017 (1)
- February 2017 (2)
- January 2017 (1)
- December 2016 (1)
- October 2016 (1)
What can the pharmaceutical industry learn from Netflix?
Four years after its initial EU market authorisation, NICE recommended Celgene’s Revlimid® as a first-line treatment in...
Will technology know more about us than we know about ourselves?
I recently attended the Wired Health Conference at the Francis Crick Institute in London. Dolby Laboratories’ chief scientist Poppy Crum...
5 key challenges for Biotech surrounding smaller patient populations and targeted therapies in Biotech - Part 1 of 5
Orphan drug medicines and therapies targeting small patient populations have, in recent years, generated excitement across government,...
Can the antimicrobial resistance crisis be averted?
The oft-touted statistic that 10 million people a year will die worldwide by 2050 due to antimicrobial resistance (AMR) is stark but for...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net